<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Experimental Diabetes Research via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Experimental Diabetes Research' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Experimental+Diabetes+Research&t=Experimental+Diabetes+Research&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 21 Mar 2010 15:01:43 +0100</lastBuildDate>
        <item>
            <title>The Roles of Streptozotocin Neurotoxicity and Neutral Endopeptidase in Murine Experimental Diabetic Neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=3233196&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F431980.html</link>
            <description>In this study we explored the role of NEP in neuropathy related to either insulin-deficient diabetes or diet-induced obesity using NEP deficient (&amp;#x02212;/&amp;#x02212;) mice. Initial studies showed that streptozotocin, in the absence of subsequent hyperglycemia, did not induce nerve conduction slowing or paw thermal hypoalgesia. Glucose disposal was impaired in both C57Bl/6 and NEP &amp;#x02212;/&amp;#x02212; mice fed a high fat diet. Thermal hypoalgesia and nerve conduction slowing were present in both streptozotocin-diabetic and high fat fed C57Bl/6 mice but not in NEP &amp;#x02212;/&amp;#x02212; mice exposed to either streptozotocin-induced diabetes or a high fat diet. These studies suggest that streptozotocin does not induce neurotoxicity in mice and that NEP plays a role in regulating nerve function in...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3233196</comments>
            <pubDate>Wed, 03 Feb 2010 14:23:29 +0100</pubDate>
            <guid isPermaLink="false">3233196</guid>        </item>
        <item>
            <title>Cold Exposure Exacerbates the Development of Diabetic Polyneuropathy in the Rat</title>
            <link>http://www.medworm.com/index.php?rid=3173540&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F827943.html</link>
            <description>This study explores whether cold exposure contributes to the development of DPN. Streptozotocin-induced diabetic rats and controls were exposed to a room temperature (23&amp;#x2218;C) or cold environment (10&amp;#x2218;C). H-reflex, tail and sciatic motor, and sensory nerve conduction studies were performed. Analyses of sural nerve, intraepidermal nerve fibers, and skin and nerve nitrotyrosine ELISAs were performed. Diabetic animals exposed to a cold environment had an increased H-reflex four weeks earlier than diabetic room temperature animals (P=.03). Cold-exposed diabetic animals also had greater reduction in motor conduction velocities at 20 weeks (P=.017), decreased skin nerve fiber density (P=.037), and increased skin nitrotyrosine levels (P=.047). Cold exposure appears to hasten the develop...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3173540</comments>
            <pubDate>Fri, 15 Jan 2010 14:11:02 +0100</pubDate>
            <guid isPermaLink="false">3173540</guid>        </item>
        <item>
            <title>Identification of Compounds That Inhibit IGF-I Signaling in Hyperglycemia</title>
            <link>http://www.medworm.com/index.php?rid=3143932&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F267107.html</link>
            <description>Increased 
         responsiveness of vascular cells to the growth 
         factor IGF-I has been implicated in 
         complications associated with diabetes. Here we 
         describe the development of an assay and 
         screening of a library of compounds for their 
         ability to accelerate cleavage of the 
         transmembrane protein integrin-associated 
         protein (IAP) thereby disrupting the association 
         between IAP and SHPS-1 which we have shown as 
         critical for the enhanced response of vascular 
         cells to IGF-I. The cell-based ELISA utilizes an 
         antibody that specifically detects cleaved, but 
         not intact, IAP. Of the 1040 compounds tested, 14 
         were considered active by virtue of their 
         ability to ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3143932</comments>
            <pubDate>Wed, 06 Jan 2010 14:10:59 +0100</pubDate>
            <guid isPermaLink="false">3143932</guid>        </item>
        <item>
            <title>Glinide, but Not Sulfonylurea, Can Evoke Insulin Exocytosis by Repetitive Stimulation: Imaging Analysis of Insulin Exocytosis by Secretagogue-Induced Repetitive Stimulations</title>
            <link>http://www.medworm.com/index.php?rid=3123802&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F278762.html</link>
            <description>To investigate the different effects between sulfonylurea (SU) and glinide drugs in insulin secretion, pancreatic &amp;#x03B2;-cells were repeatedly stimulated with SU (glimepiride) or glinide (mitiglinide). Total internal reflection fluorescent (TIRF) microscopy revealed that secondary stimulation with glimepiride, but not glucose and mitiglinide, failed to evoke fusions of insulin granules although primary stimulation with glucose, glimepiride, and mitiglinide induced equivalent numbers of exocytotic responses. Glimepiride, but not glucose and mitiglinide, induced abnormally sustained [Ca2+]i elevations and reductions of docked insulin granules on the plasma membrane. Our data suggest that the effect of glinide on insulin secretory mechanisms is similar to that of glucose. (Source: Experimen...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3123802</comments>
            <pubDate>Mon, 28 Dec 2009 14:09:48 +0100</pubDate>
            <guid isPermaLink="false">3123802</guid>        </item>
        <item>
            <title>Trp64Arg Polymorphism in Beta3-Adrenergic Receptor Gene Is Associated with Decreased Fat Oxidation Both in Resting and Aerobic Exercise in the Japanese Male</title>
            <link>http://www.medworm.com/index.php?rid=3109260&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F605139.html</link>
            <description>The purpose of our study was to investigate whether the Trp64Arg polymorphism in &amp;#x03B2;3-AR gene and the &amp;#x2212;3826A/G polymorphism in the UCP1 gene were associated with the reduction in energy expenditure and fat oxidation both in resting and aerobic exercise in Japanese. Eighty-six nonobese young healthy Japanese were recruited. Energy expenditure was measured using indirect calorimetry. The subjects performed an aerobic exercise program at 60&amp;#37; of their maximal heart rate for 30 minutes. The level of fat oxidation at rest and aerobic exercise of the male subjects with Trp/Arg of the &amp;#x03B2;3-AR gene was significantly lower than that of the Trp/Trp genotype. No difference in FO0-30 was observed in the female subjects. There was no association between UCP-1 polymorphism and energy...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3109260</comments>
            <pubDate>Tue, 22 Dec 2009 14:10:21 +0100</pubDate>
            <guid isPermaLink="false">3109260</guid>        </item>
        <item>
            <title>Can Henna Prevent Ulceration in Diabetic Feet at High Risk?</title>
            <link>http://www.medworm.com/index.php?rid=3027970&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F107496.html</link>
            <description>(Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3027970</comments>
            <pubDate>Thu, 26 Nov 2009 14:16:27 +0100</pubDate>
            <guid isPermaLink="false">3027970</guid>        </item>
        <item>
            <title>Skeletal Muscle Sorbitol Levels in Diabetic Rats with and without Insulin Therapy and Endurance Exercise Training</title>
            <link>http://www.medworm.com/index.php?rid=3017822&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F737686.html</link>
            <description>Sorbitol accumulation 
         is postulated to play a role in skeletal muscle 
         dysfunction associated with diabetes. The 
         purpose of this study was to determine the 
         effects of insulin and of endurance exercise on 
         skeletal muscle sorbitol levels in 
         streptozotocin-induced diabetic rats. Rats were 
         assigned to one experimental group (control 
         sedentary, control exercise, diabetic sedentary, 
         diabetic exercise, diabetic sedentary 
         no-insulin). Diabetic rats received daily 
         subcutaneous insulin. The exercise-trained rats 
         ran on a treadmill (1 hour, 5X/wk, for 
         12 weeks). Skeletal muscle sorbitol levels 
         were the highest in the diabetic sedentary 
         no-insulin group. ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3017822</comments>
            <pubDate>Mon, 23 Nov 2009 14:05:41 +0100</pubDate>
            <guid isPermaLink="false">3017822</guid>        </item>
        <item>
            <title>Prevalence of Metabolic Syndrome in an Adult Urban Population of the West of Iran</title>
            <link>http://www.medworm.com/index.php?rid=2956316&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F136501.html</link>
            <description>Conclusions. There is a high prevalence of metabolic syndrome in this urban population of the northern west of Iran. Focus of cardiovascular prevention should be undertaken in this area. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2956316</comments>
            <pubDate>Wed, 04 Nov 2009 14:17:38 +0100</pubDate>
            <guid isPermaLink="false">2956316</guid>        </item>
        <item>
            <title>Murine Pancreatic Beta TC3 Cells Show Greater 2&amp;#x2032;,5&amp;#x2032;-Oligoadenylate Synthetase (2&amp;#x2032;5&amp;#x2032;AS) Antiviral Enzyme Activity and Apoptosis Following IFN-&amp;#x03B1;
 or Poly(I:C) Treatment than Pancreatic Alpha TC3 Cells</title>
            <link>http://www.medworm.com/index.php?rid=2936439&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F631026.html</link>
            <description>Type 1 diabetes is caused by autoimmune destruction of pancreatic beta cells, possibly virus initiated. Virus infection induces alpha-interferon (IFN-&amp;#x03B1;), leading to upregulation of genes encoding double-stranded (ds) RNA-dependent antiviral enzymes 2&amp;#x2032;,5&amp;#x2032;-oligoadenylate synthetase (2&amp;#x2032;5&amp;#x2032;AS) and PKR (p68). To investigate whether beta cell specificity could be due to antiviral differences between beta and alpha cells, we treated beta and alpha TC3 cell lines with IFN-&amp;#x03B1; and/or poly(I:C) (a synthetic dsRNA). Results showed that, following IFN-&amp;#x03B1; stimulation, increases in 2&amp;#x2032;5&amp;#x2032;AS levels and activities were significantly higher in beta than alpha cells (P&amp;#x003C;.001), whereas increases in PKR level and activity were comparable in the tw...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2936439</comments>
            <pubDate>Thu, 29 Oct 2009 14:11:31 +0100</pubDate>
            <guid isPermaLink="false">2936439</guid>        </item>
        <item>
            <title>Influence of Overt Diabetes Mellitus on Cyclosporine Pharmacokinetics in a Canine Model</title>
            <link>http://www.medworm.com/index.php?rid=2906272&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F363787.html</link>
            <description>Conclusion. Overt diabetes alters cyclosporine disposition by modulating its clearance. Abnormalities in the lipid profile, among other factors, may contribute to the accelerated metabolic degradation of cyclosporine under hyperglycemic conditions. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2906272</comments>
            <pubDate>Tue, 20 Oct 2009 13:11:20 +0100</pubDate>
            <guid isPermaLink="false">2906272</guid>        </item>
        <item>
            <title>Dynamic Changes of Neuroskeletal Proteins in DRGs Underlie Impaired Axonal Maturation and Progressive Axonal Degeneration in Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2881859&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F793281.html</link>
            <description>We investigated mechanisms underlying progressive axonal dysfunction and structural deficits in type 1&amp;#x02009;BB/Wor-rats from 1&amp;#x2009;week to 10&amp;#x2009;month diabetes duration. Motor and sensory conduction velocities were decreased after 4 and 6&amp;#x2009;weeks of diabetes and declined further over the remaining 9 months. Myelinated sural nerve fibers showed progressive deficits in fiber numbers and sizes. Structural deficits in unmyelinated axonal size were evident at 2&amp;#x2009;month and deficits in number were present at 4&amp;#x2009;mo. These changes were preceded by decreased availability of insulin, C-peptide and IGF-1 and decreased expression of neurofilaments and &amp;#x03B2;-III-tubulin. Upregulation of phosphorylating stress kinases like Cdk5, p-GSK-3&amp;#x03B2;, and p42/44 resulted in increa...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2881859</comments>
            <pubDate>Mon, 12 Oct 2009 13:07:07 +0100</pubDate>
            <guid isPermaLink="false">2881859</guid>        </item>
        <item>
            <title>Structural and Ultrastructural Analysis of Cerebral Cortex, Cerebellum, and Hypothalamus from Diabetic Rats</title>
            <link>http://www.medworm.com/index.php?rid=2848357&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F329632.html</link>
            <description>Autonomic and peripheral neuropathies are well-described complications in diabetes. Diabetes mellitus is also associated to central nervous system damage. This little-known complication is characterized by impairment of brain functions and electrophysiological changes associated with neurochemical and structural abnormalities. The purpose of this study was to investigate brain structural and ultrastructural changes in rats with streptozotocin-induced diabetes. Cerebral cortex, hypothalamus, and cerebellum were obtained from controls and 8 weeks diabetic rats. Light and electron microscope studies showed degenerative changes of neurons and glia, perivascular and mitochondrial swelling, disarrangement of myelin sheath, increased area of myelinated axons, presynaptic vesicle dispersion in swo...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2848357</comments>
            <pubDate>Thu, 01 Oct 2009 16:36:29 +0100</pubDate>
            <guid isPermaLink="false">2848357</guid>        </item>
        <item>
            <title>Positive Correlation of PTH-Related Peptide with Glucose in Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2749066&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F291027.html</link>
            <description>In conclusion, the strong positive relation of PTHrP with glucose in the fasting state in patients with type 2 diabetes mellitus raises several questions for further experimentation concerning its exact role and physiological significance. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2749066</comments>
            <pubDate>Tue, 01 Sep 2009 12:05:20 +0100</pubDate>
            <guid isPermaLink="false">2749066</guid>        </item>
        <item>
            <title>Effect of Food Restriction on Adipose Tissue in Spontaneously Diabetic Torii Fatty Rats</title>
            <link>http://www.medworm.com/index.php?rid=2710429&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F715057.html</link>
            <description>In this study, SDT fatty rats were subjected to pair-feeding with SDT-+/+ (SDT) rats from 6 to 22 weeks of age. The ratio of visceral fat weight to subcutaneous fat weight (V/S) decreased at 12 weeks of age in the pair-feeding rats. The intraperitoneal fat weight such as epididymal and retroperitoneal fat weight decreased, whereas mesenteric fat weight had no change. Cell size of the epididymal fat in the pair-feeding rats tended to decrease. Glucose oxidation level in epididymal fat in the pair-feeding rats at 12 weeks of age was recovered to a similar level with that in SDT rats. These results indicated that SDT fatty rat is a useful model to evaluate the functional or the morphological features in adipose tissue and develop a novel drug for antiobesity. (Source: Experimental Diabetes Re...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710429</comments>
            <pubDate>Wed, 19 Aug 2009 10:22:15 +0100</pubDate>
            <guid isPermaLink="false">2710429</guid>        </item>
        <item>
            <title>Rosiglitazone Prevents High Glucose-Induced Vascular Endothelial Growth Factor and Collagen IV Expression in Cultured Mesangial Cells</title>
            <link>http://www.medworm.com/index.php?rid=2574359&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F910783.html</link>
            <description>Peroxisome proliferator-activated receptor (PPAR&amp;#x03B3;), a ligand-dependent transcription factor, negatively modulates high glucose effects. We postulated that rosiglitazone (RSG), an activator of PPAR&amp;#x03B3; prevents the upregulation of vascular endothelial growth factor (VEGF) and collagen IV by mesangial cells exposed to high glucose. Primary cultured rat mesangial cells were growth-arrested in 5.6&amp;#x2009;mM (NG) or 25&amp;#x2009;mM D-glucose (HG) for up to 48&amp;#x2009;hours. In HG, PPAR&amp;#x03B3; mRNA and protein were reduced within 3&amp;#x2009;h, and enhanced ROS generation, expression of p22phox, VEGF and collagen IV, and PKC-&amp;#x03B6; membrane association were prevented by RSG. In NG, inhibition of PPAR&amp;#x03B3; caused ROS generation and VEGF expression that were unchanged by RSG. Reduced AMP...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574359</comments>
            <pubDate>Tue, 07 Jul 2009 10:53:45 +0100</pubDate>
            <guid isPermaLink="false">2574359</guid>        </item>
        <item>
            <title>A Variation in the Cerebroside Sulfotransferase Gene Is Linked to Exercise-Modified Insulin Resistance and to Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2572256&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F429593.html</link>
            <description>Conclusion. Heterozygosity at SNP rs2267161 in the gene encoding the CST enzyme confers increased risk of T2D. Females with the CC allele showed lower insulin resistance. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2572256</comments>
            <pubDate>Mon, 06 Jul 2009 10:51:56 +0100</pubDate>
            <guid isPermaLink="false">2572256</guid>        </item>
        <item>
            <title>Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide</title>
            <link>http://www.medworm.com/index.php?rid=2465309&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F819123.html</link>
            <description>Patients with fulminant type 1 diabetes almost completely lack
C-peptide even soon after the onset of the disease, and the deficiency
continues for the rest of their life. Thus, fulminant type 1 diabetes
could serve as a good model of nature to explore the physiological role
of C-peptide. For example, patients with fulminant type 1 diabetes have
diabetic chronic complications more frequently than those with classical
autoimmune type 1 diabetes 5 years after the onset of diabetes, and the
higher prevalence could be partly attributable to the complete lack of
C-peptide in fulminant type 1 diabetes. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465309</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465309</guid>        </item>
        <item>
            <title>The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor-rat</title>
            <link>http://www.medworm.com/index.php?rid=2465308&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F230458.html</link>
            <description>Diabetic polyneuropathy (DPN) occurs more frequently in type 1 diabetes resulting in a more severe DPN. The differences in DPN between the two types of diabetes are due to differences in the availability of insulin and C-peptide. Insulin and C-peptide provide gene regulatory effects on neurotrophic factors with effects on axonal cytoskeletal proteins and nerve fiber integrity. A significant abnormality in type 1 DPN is nodal degeneration. In the type 1 BB/Wor-rat, C-peptide replacement corrects metabolic abnormalities ameliorating the acute nerve conduction defect. It corrects abnormalities of neurotrophic factors and the expression of neuroskeletal proteins with improvements of axonal size and function. C-peptide corrects the expression of nodal adhesive molecules with prevention and repa...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465308</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465308</guid>        </item>
        <item>
            <title>Radioiodinated Naphthylalanine Derivatives Targeting Pancreatic Beta Cells in Normal and Nonobese Diabetic Mice</title>
            <link>http://www.medworm.com/index.php?rid=2465307&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F371716.html</link>
            <description>An imaging method capable of using a signal from pancreatic beta cells to determine their mass would be of immense value in monitoring the progression of diabetes as well as response to treatment. Somatostatin receptors (SSTRs) are expressed on beta cells and are a potential target for imaging. The main objective of this study was to investigate whether pancreatic beta cells are a target for radiolabeled naphthylalanine derivatives. The molecules were subjected to in vitro and ex vivo evaluations. Pancreatic uptake of radioactivity was lower in nonobese diabetic (NOD) mice than normal mice at all time points investigated (P &amp;#60; .05) and correlated with the number of islets in tissue sections of both control and NOD mice. Immunohistochemical and confocal fluorescent microscopic studies sh...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465307</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465307</guid>        </item>
        <item>
            <title>Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in &amp;#x03B2;-Cell Death  in Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=2465306&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F421287.html</link>
            <description>The presence of fibrillar protein deposits (amyloid) of human islet amyloid polypeptide (hIAPP) in the pancreatic islets of Langerhans is thought to be related to death of the insulin-producing islet &amp;#x03B2;-cells in type 2 diabetes mellitus (DM2). The mechanism of hIAPP-induced &amp;#x03B2;-cell death is not understood. However, there is growing evidence that hIAPP-induced disruption of &amp;#x03B2;-cell membranes is the cause of hIAPP cytotoxicity. Amyloid cytotoxicity by membrane damage has not only been suggested for hIAPP, but also for peptides and proteins related to other misfolding diseases, like Alzheimer_s disease, Parkinson&amp;#39;s disease, and prion diseases. Here we review the interaction of hIAPP with membranes, and discuss recent progress in the field, with a focus on hIAPP structure...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465306</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465306</guid>        </item>
        <item>
            <title>C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients</title>
            <link>http://www.medworm.com/index.php?rid=2465305&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F730594.html</link>
            <description>Conclusion/interpretation. C-peptide and its C-terminal fragments are equally effective in improving erythrocyte deformability in type 1 diabetes. The C-terminal residues of C-peptide are causally involved in this effect. The signal transduction pathway is Ca2+-dependent and involves activation of red blood cell Na+,K+-ATPase. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465305</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465305</guid>        </item>
        <item>
            <title>Human Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=2465304&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F697035.html</link>
            <description>In this study, we found that after a long-term, high-fat diet challenge islet amyloid was observed in only 4 of 19 hIAPP transgenic mice. hIAPP transgenic females exhibited severe glucose intolerance, which was associated with a downregulation of GLUT-2 mRNA expression. In isolated islets from hIAPP males cultured for 3 weeks on high-glucose medium, the percentage of amyloid containing islets increased from 5.5&amp;#37; to 70&amp;#37;. This ex vivo system will allow a more rapid, convenient, and specific study of factors influencing islet amyloidosis as well as of therapeutic strategies to interfere with this pathological process. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465304</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465304</guid>        </item>
        <item>
            <title>History and Diagnostic Significance of C-Peptide</title>
            <link>http://www.medworm.com/index.php?rid=2465303&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F576862.html</link>
            <description>Starting with the epoch-making discovery of proinsulin, C-peptide has played an important interdisciplinary role, both as part of the single-chain precursor molecule and as an individual entity. In the pioneering years, fundamental systematic experiments unravelled new biochemical mechanisms and chemical structures. After the first detection of C-peptide in human serum, it quickly became a most useful independent indicator of insulin biosynthesis and secretion, finding application in a rapidly growing number of clinical investigations. A prerequisite was the development of specific immuno assays for proinsulin and C-peptide.
Further milestones were: the chemical synthesis of several C-peptides and the accomplishments in the synthesis of proinsulin; the detection of preproinsulin with its b...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465303</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465303</guid>        </item>
        <item>
            <title>C-Peptide Effects on Renal Physiology and Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2465302&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F281536.html</link>
            <description>The C-peptide of proinsulin is important for the biosynthesis of insulin and has for a long time been considered to be biologically inert. Animal studies have shown that some of the renal effects of the C-peptide may in part be explained by its ability to stimulate the Na,K-ATPase activity. Precisely, the C-peptide reduces diabetes-induced glomerular hyperfiltration both in animals and humans, therefore, resulting in regression of fibrosis. The tubular function is also concerned as diabetic animals supplemented with C-peptide exhibit better renal function resulting in reduced urinary sodium waste and protein excretion together with the reduction of the diabetes-induced glomerular hyperfiltration. The tubular effectors of C-peptide were considered to be tubule transporters, but recent studi...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465302</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465302</guid>        </item>
        <item>
            <title>Diabetes Alters Contraction-Induced Mitogen Activated Protein Kinase Activation in the Rat Soleus and Plantaris</title>
            <link>http://www.medworm.com/index.php?rid=2465301&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F738101.html</link>
            <description>The prescription of anaerobic exercise has recently been advocated for the management of diabetes; however exercise-induced signaling in diabetic muscle remains largely unexplored. Evidence from exercise studies in nondiabetics suggests that the extracellular-signal-regulated kinases (Erk1/2), p38, and c-JUN NH2-terminal kinase (Jnk) mitogen-activated protein kinases (MAPKs) are important regulators of muscle adaptation. Here, we compare the basal and the in situ contraction-induced phosphorylation of Erk1/2- p38- and Jnk-MAPK and their downstream targets (p90rsk and MAPKAP-K2) in the plantaris and soleus muscles of normal and obese (fa/fa) Zucker rats. Compared to lean animals, the time course and magnitude of Erk1/2, p90rsk and p38 phosphorylation to a single bout of contractile stimuli ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465301</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465301</guid>        </item>
        <item>
            <title>Real-Time Monitoring of Apoptosis by Caspase-3-Like Protease Induced FRET Reduction Triggered by Amyloid Aggregation</title>
            <link>http://www.medworm.com/index.php?rid=2465300&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F865850.html</link>
            <description>Amyloid formation is cytotoxic and can activate the caspase cascade. Here, we monitor caspase-3-like activity as reduction of fluorescence resonance energy transfer (FRET) using the contstruct pFRET2-DEVD containing enhanced cyan fluorescent protin (EYFP) linked by the caspase-3 specific cleavage site residues DEVD. Beta-TC-6 cells were transfected, and the fluoorescence was measured at 440&amp;#x2009;nm excitation and 535&amp;#x2009;nm (EYFP) and 480&amp;#x2009;nm (ECFP) emission wavelength. Cells were incubated with recombinant pro lset Amyloid Polypeptide (rec prolAPP) or the processing metabolites of prolAPP;  the N-terminal flanking peptide withIAPP (recN+IAPP); IAPP with the C-terminal flanking peptied (recIAPP+C) and lslet Amyloid Polypeptide (recIAPP) . Peptides were added in solubilized from ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465300</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465300</guid>        </item>
        <item>
            <title>The Role of the 14&amp;#8211;20 Domain of the Islet Amyloid Polypeptide in Amyloid Formation</title>
            <link>http://www.medworm.com/index.php?rid=2465299&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F256954.html</link>
            <description>The molecular mechanism of amyloid formation by the islet amyloid polypeptide (IAPP) has been intensively studied since its identification in the late 1980s. The IAPP(20&amp;#8211;29) region is considered to be the central amyloidogenic module of the polypeptide. This assumption is mainly based on the amyloidogenic properties of the region and on the large sequence diversity within this region between the human and mouse IAPP, as the mouse IAPP does not form amyloids. A few years ago, another region within IAPP was identified that seems to be at least as important as IAPP(20&amp;#8211;29) in facilitation of molecular recognition that leads to amyloid formation. Here, we reinforce our and others' previous findings by analyzing supporting evidence from the recent literature. Moreover, we provide new...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465299</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465299</guid>        </item>
        <item>
            <title>Acute-Phase Serum Amyloid A as a Marker of Insulin Resistance in Mice</title>
            <link>http://www.medworm.com/index.php?rid=2465298&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F230837.html</link>
            <description>Acute-phase serum amyloid A (A-SAA) was shown recently to correlate with obesity and insulin resistance in humans. However, the mechanisms linking obesity-associated inflammation and elevated plasma A-SAA to insulin resistance are poorly understood. Using high-fat diet- (HFD-) fed mice, we found that plasma A-SAA was increased early upon HFD feeding and was tightly associated with systemic insulin resistance. Plasma A-SAA elevation was due to induction of Saa1 and Saa2 expression in liver but not in adipose tissue. In adipose tissue Saa3 was the predominant isoform and the earliest inflammatory marker induced, suggesting it is important for initiation of adipose tissue inflammation. To assess the potential impact of A-SAA on adipose tissue insulin resistance, we treated 3T3-L1 adipocytes w...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465298</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465298</guid>        </item>
        <item>
            <title>Disturbed &amp;#x03B1;-Cell Function in Mice with &amp;#x03B2;-Cell Specific Overexpression of Human Islet Amyloid Polypeptide</title>
            <link>http://www.medworm.com/index.php?rid=2465297&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F304513.html</link>
            <description>This study examined &amp;#x03B1;-cell function in mice with &amp;#x03B2;-cell specific overexpression of human IAPP (hIAPP) after an oral protein gavage (75&amp;#x2009;mg whey protein/mouse). Baseline glucagon levels were higher in transgenic mice (41&amp;#x00B1;4.0&amp;#x2009;pg/mL, n=6) than in wildtype animals (19&amp;#x00B1;5.1&amp;#x2009;pg/mL, n=5, P=.015). In contrast, the glucagon response to protein was impaired in transgenic animals (21&amp;#x00B1;2.7&amp;#x2009;pg/mL in transgenic mice versus 38&amp;#x00B1;5.7&amp;#x2009;pg/mL in wildtype mice at 15 minutes; P=.027). Baseline insulin levels did not differ between the groups, while the insulin response, as the glucagon response, was impaired after protein challenge (P=.018). Glucose levels were not different between the groups and did not change significantly after protein...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465297</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465297</guid>        </item>
        <item>
            <title>Pancreatic Beta-Cell Purification by Altering FAD and NAD(P)H Metabolism</title>
            <link>http://www.medworm.com/index.php?rid=2465296&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F165360.html</link>
            <description>In this study, we investigated whether rat beta cells can be isolated from nonbeta endocrine cells by manipulating the flavin adenine dinucleotide (FAD) and nicotinamide-adenine dinucleotide phosphate (NAD(P)H) autofluorescence. Beta cells were isolated from dispersed islets by flow cytometry, based on their high FAD and NAD(P)H fluorescence. To improve beta cell yield and purity, the cellular FAD and NAD(P)H contents were altered by preincubation in culture media containing varying amounts of D-glucose and amino acids. Manipulation of the cellular FAD and NAD(P)H fluorescence improves beta cell yield and purity after sorting. This method is also a fast and reliable method to measure beta cell functional viability. A conceivable application is assessing beta cell viability before transplan...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465296</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465296</guid>        </item>
        <item>
            <title>Role of C-Peptide in the Regulation of Microvascular Blood Flow</title>
            <link>http://www.medworm.com/index.php?rid=2465295&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F176245.html</link>
            <description>During the recent years, the role of C-peptide, released from the pancreatic beta cell, in regulating microvascular blood flow, has received increasing attention. In type 1 diabetic patients, intravenous application of C-peptide in physiological concentrations was shown to increase microvascular blood flow, and to improve microvascular endothelial function and the endothelial release of NO. C-peptide was shown to impact microvascular blood flow by several interactive pathways, like stimulating Na+K+ATPase or the endothelial release of NO. There is increasing evidence, that in patients with declining beta cell function, the lack of C-peptide secretion might play a putative role in the development of microvascular blood flow abnormalities, which go beyond the effects of declining insulin sec...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465295</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465295</guid>        </item>
        <item>
            <title>Maternal Enterovirus Infection during Pregnancy as a Risk Factor in Offspring Diagnosed with Type 1 Diabetes between 15 and 30 Years of Age</title>
            <link>http://www.medworm.com/index.php?rid=2465294&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F271958.html</link>
            <description>Maternal enterovirus infections during pregnancy may increase the risk of offspring developing type 1 diabetes during childhood. The aim of this study was to investigate whether gestational enterovirus infections increase the offspring&amp;#39;s risk of type 1 diabetes later in life. Serum samples from 30 mothers without diabetes whose offspring developed type 1 diabetes between 15 and 25 years of age were analyzed for enterovirus-specific immunoglobulin M (IgM) antibodies and enterovirus genome (RNA), and compared to a control group. Among the index mothers, 9/30 (30&amp;#37;) were enterovirus IgM-positive, and none was positive for enterovirus RNA. In the control group, 14/90 (16&amp;#37;) were enterovirus IgM-positive, and 4/90 (4&amp;#37;) were positive for enterovirus RNA (n.s.). Boys of enterovirus ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465294</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465294</guid>        </item>
        <item>
            <title>Phlorizin Prevents Glomerular Hyperfiltration but not Hypertrophy in Diabetic Rats</title>
            <link>http://www.medworm.com/index.php?rid=2465293&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F305403.html</link>
            <description>The relationships of renal and glomerular hypertrophies to development of hyperfiltration and proteinuria early in streptozotocin-induced diabetes were explored. Control, diabetic, phlorizin-treated controls, and diabetic male Fischer rats were used. Phlorizin (an Na+-glucose cotransport inhibitor) was given at a dose sufficient to normalize blood glucose. Inulin clearance (Cinulin) and protein excretion rate (PER) were measured. For morphometry, kidney sections were stained with periodic acid Schiff. At one week, diabetes PER increased 2.8-folds (P&amp;#x003C;.001), Cinulin increased 80&amp;#37; (P&amp;#x003C;.01). Kidney wet and dry weights increased 10&amp;#37;&amp;#8211;12&amp;#37; (P&amp;#x003C;.05), and glomerular tuft area increased 9.3&amp;#37; (P&amp;#x003C;.001). Phlorizin prevented proteinuria, hyperfiltration, an...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465293</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465293</guid>        </item>
        <item>
            <title>Change in Long-Spacing Collagen in Descemet&amp;#39;s Membrane of Diabetic Goto-Kakizaki Rats
                        and Its Suppression by Antidiabetic Agents</title>
            <link>http://www.medworm.com/index.php?rid=2465292&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F818341.html</link>
            <description>We examined changes in the ultrastructure and localization of major extracellular matrix components, including 5 types of collagen (type I, III, IV, VI, and VIII), laminin, fibronectin, and heparan sulfate proteoglycan in Descemet&amp;#39;s membrane of the cornea of diabetic GK rats. In the cornea of diabetic GK rats, more long-spacing collagen fibrils were observed in Descemet&amp;#39;s membrane than in the membrane of the nondiabetic Wistar rats. Both GK and Wistar rats showed an age-dependent increase in the density of the long-spacing collagen. Immunoelectron microscopy showed that type VIII collagen was localized in the internodal region of the long-spacing collagen, which was not labelled by any of the other antibodies used. The antidiabetic agents nateglinide and glibenclamide significantly...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465292</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465292</guid>        </item>
        <item>
            <title>GeneSpeed Beta Cell: An Online Genomics Data Repository and Analysis Resource Tailored for the Islet Cell Biologist</title>
            <link>http://www.medworm.com/index.php?rid=2465291&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F312060.html</link>
            <description>Conclusions. The combination of an exhaustive domain-based compilation of the transcriptome with gene array data of interest to the islet biologist affords novel methods for multidimensional querying between individual datasets in a rapid fashion, presently not available elsewhere. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465291</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465291</guid>        </item>
        <item>
            <title>New Tricks by an Old Dog</title>
            <link>http://www.medworm.com/index.php?rid=2465290&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F384219.html</link>
            <description>(Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465290</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465290</guid>        </item>
        <item>
            <title>Transthyretin and Amyloid in the Islets of Langerhans in Type-2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2465289&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F429274.html</link>
            <description>Transthyretin (TTR) is a major amyloid fibril protein in certain systemic forms of amyloidosis. It is a plasma protein, mainly synthesized by the liver but expression occurs also at certain minor locations, including the endocrine cells in the islets of Langerhans. With the use of immunohistochemistry and in situ hybridization, we have studied the distribution of transthyretin-containing cells in islets of Langerhans in type-2 diabetic and nondiabetic individuals. TTR expression was particularly seen in alpha (glucagon) cells. Islets from type-2 diabetic patients had proportionally more transthyretin-reactive islet cells, including beta cells. A weak transthyretin immunoreaction in IAPP-derived amyloid occurred in some specimens. In seeding experiments in vitro, we found that TTR fibrils d...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465289</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465289</guid>        </item>
        <item>
            <title>Evaluation of Bcl-2 Family Gene Expression and Caspase-3 Activity in Hippocampus STZ-Induced Diabetic Rats</title>
            <link>http://www.medworm.com/index.php?rid=2465288&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F638467.html</link>
            <description>We assessed the expression of Bcl-2 family members at both mRNA and protein levels as well as the Caspase-3 activity, in order to investigate the occurrence of apoptosis in hippocampus of STZ-induced diabetic rats. We selected twenty-four Wistar rats; half of them were made diabetic by intraperitoneal injection of a single 60&amp;#x2009;mg/kg dose of streptozotocin (STZ, IP), while the others received normal saline and served as controls. The expressions of Bcl-2, Bcl-xL, and Bax mRNA and proteins were measured using RT-PCR and western blotting, respectively. Caspases-3 activity was determined by using the Caspase-3/CPP32 Fluorometric Assay Kit. The result showed that mRNA 
and protein levels of Bcl-2 and Bcl-xL were lower in hippocampus of diabetic group than that of the control group, wherea...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465288</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465288</guid>        </item>
        <item>
            <title>The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model</title>
            <link>http://www.medworm.com/index.php?rid=2465287&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F704045.html</link>
            <description>Conclusion. Together, these results indicated that high-fat diet combined with multiple low doses of STZ (30&amp;#x2009;mg/kg at weekly intervals for 2 weeks) proved to be a better way for developing a stable animal model of type 2 diabetes, and this new model may be suitable for pharmaceutical screening. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465287</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465287</guid>        </item>
        <item>
            <title>Islet Specific Wnt Activation in Human Type II Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2465286&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F728763.html</link>
            <description>We examined the expression of multiple Wnt pathway components in pancreases from normal individuals and type II diabetic individuals. Multiple members of the Wnt signaling pathway, including TCF7L2, Wnt2b, &amp;#x03B2;-catenin, pGSK3&amp;#x03B2;, TCF3, cyclinD1, and c-myc, were undetectable or expressed at low levels in islets from nondiabetic individuals, but were also upregulated specifically in islets of type II diabetic patients. Culture of pancreatic tissue and islet isolation led to Wnt activation that was reversed by the Wnt antagonist sFRP, demonstrating that Wnt activation in that setting was due to soluble Wnt factors. These data support a model in which the Wnt pathway plays a dynamic role in the pathogenesis of type II diabetes and suggest manipulation of Wnt signaling as a new approac...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465286</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465286</guid>        </item>
        <item>
            <title>Amyloid Deposition in Transplanted Human Pancreatic Islets: A Conceivable Cause of Their Long-Term Failure</title>
            <link>http://www.medworm.com/index.php?rid=2465285&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F562985.html</link>
            <description>Following the encouraging report of the Edmonton group, there was a rejuvenation of the islet transplantation field. After that, more pessimistic views spread when long-term results of the clinical outcome were published. A progressive loss of the &amp;#x3B2;-cell function meant that almost all patients were back on insulin therapy after 5 years. More than 10 years ago, we demonstrated that amyloid deposits rapidly formed in human islets and in mouse islets transgenic for human IAPP when grafted into nude mice. It is, therefore, conceivable to consider amyloid formation as one potential candidate for the long-term failure. The present paper reviews attempts in our laboratories to elucidate the dynamics of and mechanisms behind the formation of amyloid in transplanted islets with special emphas...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465285</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465285</guid>        </item>
        <item>
            <title>Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=2465284&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F897508.html</link>
            <description>Conclusion/interpretation. Decreased ADPRCA significantly correlated with diabetic nephropathy. ADPRCA in PBMCs would be an important marker associated with diabetic nephropathy. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465284</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465284</guid>        </item>
        <item>
            <title>Importance of Aggregated Islet Amyloid Polypeptide for the Progressive Beta-Cell Failure in Type 2 Diabetes and in Transplanted Human Islets</title>
            <link>http://www.medworm.com/index.php?rid=2465283&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2008%2F528354.html</link>
            <description>(Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465283</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465283</guid>        </item>
        <item>
            <title>The Metal Chelators, Trientine and Citrate, Inhibit the Development of Cardiac Pathology in the Zucker Diabetic Rat</title>
            <link>http://www.medworm.com/index.php?rid=2465282&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F696378.html</link>
            <description>Conclusion. Dietary supplementation with trientine and citric acid significantly prevented structural and functional changes in the diabetic heart, supporting the merits of mild chelators for prevention of cardiovascular disease in diabetes. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465282</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465282</guid>        </item>
        <item>
            <title>Sequence Variation and Expression of the Gimap Gene Family in the BB Rat</title>
            <link>http://www.medworm.com/index.php?rid=2465281&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F835650.html</link>
            <description>Positional cloning of lymphopenia (lyp) in the BB rat revealed a frameshift mutation in Gimap5, a member of at least seven related GTPase Immune Associated Protein genes located on rat chromosome 4q24. Our aim was to clone and sequence the cDNA of the BB diabetes prone (DP) and diabetes resistant (DR) alleles of all seven Gimap genes in the congenic DR.lyp rat line with 2 Mb of BB DP DNA introgressed onto the DR genetic background. All (100&amp;#37;) DR.lyp/lyp rats are lymphopenic and develop type 1 diabetes (T1D) by 84 days of age while DR.+/+ rats remain T1D and lyp resistant. Among the seven Gimap genes, the Gimap5 frameshift mutation, a mutant allele that produces no protein, had the greatest impact on lymphopenia in the DR.lyp/lyp rat. Gimap4 and Gimap1 each had one amino acid substituti...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465281</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465281</guid>        </item>
        <item>
            <title>Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688</title>
            <link>http://www.medworm.com/index.php?rid=2465280&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fedr%2F2009%2F912327.html</link>
            <description>The purpose of this study was to determine whether AVE7688 a drug that inhibits both angiotensin converting enzyme and neutral endopeptidase activity protects vascular and nerve functions in an animal model of metabolic syndrome. Obese Zucker rats at 20 weeks of age were treated for 12 weeks with AVE7688. Vasodilation in epineurial arterioles was measured by videomicroscopy and nerve conduction velocity was measured following electrical stimulation. Treatment with AVE7688 improved vascular relaxation in response to acetylcholine and motor and sensory nerve conduction velocity. In obese Zucker rats superoxide levels and nitrotyrosine staining were elevated in the aorta and treatment corrected both conditions. Obese Zucker rats were hypoalgesic in response to a thermal stimulus and demonstra...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465280</comments>
            <pubDate>Tue, 09 Jun 2009 16:47:22 +0100</pubDate>
            <guid isPermaLink="false">2465280</guid>        </item>
        <item>
            <title>Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688</title>
            <link>http://www.medworm.com/index.php?rid=2459932&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2009%2F912327</link>
            <description>The purpose of this study was to determine whether AVE7688 a drug that inhibits both angiotensin converting enzyme and neutral endopeptidase activity protects vascular and nerve functions in an animal model of metabolic syndrome. Obese Zucker rats at 20 weeks of age were treated for 12 weeks with AVE7688. Vasodilation in epineurial arterioles was measured by videomicroscopy and nerve conduction velocity was measured following electrical stimulation. Treatment with AVE7688 improved vascular relaxation in response to acetylcholine and motor and sensory nerve conduction velocity. In obese Zucker rats superoxide levels and nitrotyrosine staining were elevated in the aorta and treatment corrected both conditions. Obese Zucker rats were hypoalgesic in response to a thermal stimulus and demonstra...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2459932</comments>
            <pubDate>Sun, 07 Jun 2009 19:11:22 +0100</pubDate>
            <guid isPermaLink="false">2459932</guid>        </item>
        <item>
            <title>Sequence Variation and Expression of the Gimap Gene Family in the BB Rat</title>
            <link>http://www.medworm.com/index.php?rid=2383914&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2009%2F835650</link>
            <description>Positional cloning of lymphopenia (lyp) in the BB rat revealed a frameshift mutation in Gimap5, a member of at least seven related GTPase Immune Associated Protein genes located on rat chromosome 4q24. Our aim was to clone and sequence the cDNA of the BB diabetes prone (DP) and diabetes resistant (DR) alleles of all seven Gimap genes in the congenic DR.lyp rat line with 2 Mb of BB DP DNA introgressed onto the DR genetic background. All (100&amp;#37;) DR.lyp/lyp rats are lymphopenic and develop type 1 diabetes (T1D) by 84 days of age while DR.+/+ rats remain T1D and lyp resistant. Among the seven Gimap genes, the Gimap5 frameshift mutation, a mutant allele that produces no protein, had the greatest impact on lymphopenia in the DR.lyp/lyp rat. Gimap4 and Gimap1 each had one amino acid substituti...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2383914</comments>
            <pubDate>Sun, 03 May 2009 20:05:46 +0100</pubDate>
            <guid isPermaLink="false">2383914</guid>        </item>
        <item>
            <title>The Metal Chelators, Trientine and Citrate, Inhibit the Development of Cardiac Pathology in the Zucker Diabetic Rat</title>
            <link>http://www.medworm.com/index.php?rid=2333326&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2009%2F696378</link>
            <description>Conclusion. Dietary supplementation with trientine and citric acid significantly prevented structural and functional changes in the diabetic heart, supporting the merits of mild chelators for prevention of cardiovascular disease in diabetes. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333326</comments>
            <pubDate>Sat, 18 Apr 2009 03:51:54 +0100</pubDate>
            <guid isPermaLink="false">2333326</guid>        </item>
        <item>
            <title>Importance of Aggregated Islet Amyloid Polypeptide for the Progressive Beta-Cell Failure in Type 2 Diabetes and in Transplanted Human Islets</title>
            <link>http://www.medworm.com/index.php?rid=2308183&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F528354</link>
            <description>(Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2308183</comments>
            <pubDate>Tue, 07 Apr 2009 19:50:55 +0100</pubDate>
            <guid isPermaLink="false">2308183</guid>        </item>
        <item>
            <title>Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=2269601&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F897508</link>
            <description>Conclusion/interpretation. Decreased ADPRCA significantly correlated with diabetic nephropathy. ADPRCA in PBMCs would be an important marker associated with diabetic nephropathy. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2269601</comments>
            <pubDate>Tue, 17 Mar 2009 08:32:06 +0100</pubDate>
            <guid isPermaLink="false">2269601</guid>        </item>
        <item>
            <title>Amyloid Deposition in Transplanted Human Pancreatic Islets: A Conceivable Cause of Their Long-Term Failure</title>
            <link>http://www.medworm.com/index.php?rid=2242079&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F562985</link>
            <description>Following the encouraging report of the Edmonton group, there was a rejuvenation of the islet transplantation field. After that, more pessimistic views spread when long-term results of the clinical outcome were published. A progressive loss of the &amp;#x3B2;-cell function meant that almost all patients were back on insulin therapy after 5 years. More than 10 years ago, we demonstrated that amyloid deposits rapidly formed in human islets and in mouse islets transgenic for human IAPP when grafted into nude mice. It is, therefore, conceivable to consider amyloid formation as one potential candidate for the long-term failure. The present paper reviews attempts in our laboratories to elucidate the dynamics of and mechanisms behind the formation of amyloid in transplanted islets with special emphas...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2242079</comments>
            <pubDate>Sat, 07 Mar 2009 14:53:20 +0100</pubDate>
            <guid isPermaLink="false">2242079</guid>        </item>
        <item>
            <title>Islet Specific Wnt Activation in Human Type II Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2116788&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F728763</link>
            <description>We examined the expression of multiple Wnt pathway components in pancreases from normal individuals and type II diabetic individuals. Multiple members of the Wnt signaling pathway, including TCF7L2, Wnt2b, &amp;#x03B2;-catenin, pGSK3&amp;#x03B2;, TCF3, cyclinD1, and c-myc, were undetectable or expressed at low levels in islets from nondiabetic individuals, but were also upregulated specifically in islets of type II diabetic patients. Culture of pancreatic tissue and islet isolation led to Wnt activation that was reversed by the Wnt antagonist sFRP, demonstrating that Wnt activation in that setting was due to soluble Wnt factors. These data support a model in which the Wnt pathway plays a dynamic role in the pathogenesis of type II diabetes and suggest manipulation of Wnt signaling as a new approac...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2116788</comments>
            <pubDate>Wed, 21 Jan 2009 07:08:39 +0100</pubDate>
            <guid isPermaLink="false">2116788</guid>        </item>
        <item>
            <title>The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model</title>
            <link>http://www.medworm.com/index.php?rid=2078388&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F704045</link>
            <description>Conclusion. Together, these results indicated that high-fat diet combined with multiple low doses of STZ (30&amp;#x2009;mg/kg at weekly intervals for 2 weeks) proved to be a better way for developing a stable animal model of type 2 diabetes, and this new model may be suitable for pharmaceutical screening. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2078388</comments>
            <pubDate>Sun, 04 Jan 2009 13:22:06 +0100</pubDate>
            <guid isPermaLink="false">2078388</guid>        </item>
        <item>
            <title>Evaluation of Bcl-2 Family Gene Expression and Caspase-3 Activity in Hippocampus STZ-Induced Diabetic Rats</title>
            <link>http://www.medworm.com/index.php?rid=1871389&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F638467</link>
            <description>We assessed the expression of Bcl-2 family members at both mRNA and protein levels as well as the Caspase-3 activity, in order to investigate the occurrence of apoptosis in hippocampus of STZ-induced diabetic rats. We selected twenty-four Wistar rats; half of them were made diabetic by intraperitoneal injection of a single 60&amp;#x2009;mg/kg dose of streptozotocin (STZ, IP), while the others received normal saline and served as controls. The expressions of Bcl-2, Bcl-xL, and Bax mRNA and proteins were measured using RT-PCR and western blotting, respectively. Caspases-3 activity was determined by using the Caspase-3/CPP32 Fluorometric Assay Kit. The result showed that mRNA 
and protein levels of Bcl-2 and Bcl-xL were lower in hippocampus of diabetic group than that of the control group, wherea...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1871389</comments>
            <pubDate>Mon, 13 Oct 2008 14:47:55 +0100</pubDate>
            <guid isPermaLink="false">1871389</guid>        </item>
        <item>
            <title>Transthyretin and Amyloid in the Islets of Langerhans in Type-2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1826936&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F429274</link>
            <description>Transthyretin (TTR) is a major amyloid fibril protein in certain systemic forms of amyloidosis. It is a plasma protein, mainly synthesized by the liver but expression occurs also at certain minor locations, including the endocrine cells in the islets of Langerhans. With the use of immunohistochemistry and in situ hybridization, we have studied the distribution of transthyretin-containing cells in islets of Langerhans in type-2 diabetic and nondiabetic individuals. TTR expression was particularly seen in alpha (glucagon) cells. Islets from type-2 diabetic patients had proportionally more transthyretin-reactive islet cells, including beta cells. A weak transthyretin immunoreaction in IAPP-derived amyloid occurred in some specimens. In seeding experiments in vitro, we found that TTR fibrils d...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1826936</comments>
            <pubDate>Thu, 25 Sep 2008 18:13:50 +0100</pubDate>
            <guid isPermaLink="false">1826936</guid>        </item>
        <item>
            <title>New Tricks by an Old Dog</title>
            <link>http://www.medworm.com/index.php?rid=1803335&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F384219</link>
            <description>(Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1803335</comments>
            <pubDate>Thu, 18 Sep 2008 15:02:19 +0100</pubDate>
            <guid isPermaLink="false">1803335</guid>        </item>
        <item>
            <title>GeneSpeed Beta Cell: An Online Genomics Data Repository and Analysis Resource Tailored for the Islet Cell Biologist</title>
            <link>http://www.medworm.com/index.php?rid=1776192&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F312060</link>
            <description>Conclusions. The combination of an exhaustive domain-based compilation of the transcriptome with gene array data of interest to the islet biologist affords novel methods for multidimensional querying between individual datasets in a rapid fashion, presently not available elsewhere. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1776192</comments>
            <pubDate>Tue, 09 Sep 2008 14:39:30 +0100</pubDate>
            <guid isPermaLink="false">1776192</guid>        </item>
        <item>
            <title>Change in Long-Spacing Collagen in Descemet&amp;#39;s Membrane of Diabetic Goto-Kakizaki Rats
                        and Its Suppression by Antidiabetic Agents</title>
            <link>http://www.medworm.com/index.php?rid=1750834&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F818341</link>
            <description>We examined changes in the ultrastructure and localization of major extracellular matrix components, including 5 types of collagen (type I, III, IV, VI, and VIII), laminin, fibronectin, and heparan sulfate proteoglycan in Descemet&amp;#39;s membrane of the cornea of diabetic GK rats. In the cornea of diabetic GK rats, more long-spacing collagen fibrils were observed in Descemet&amp;#39;s membrane than in the membrane of the nondiabetic Wistar rats. Both GK and Wistar rats showed an age-dependent increase in the density of the long-spacing collagen. Immunoelectron microscopy showed that type VIII collagen was localized in the internodal region of the long-spacing collagen, which was not labelled by any of the other antibodies used. The antidiabetic agents nateglinide and glibenclamide significantly...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1750834</comments>
            <pubDate>Tue, 02 Sep 2008 13:51:28 +0100</pubDate>
            <guid isPermaLink="false">1750834</guid>        </item>
        <item>
            <title>Phlorizin Prevents Glomerular Hyperfiltration but not Hypertrophy in Diabetic Rats</title>
            <link>http://www.medworm.com/index.php?rid=1734737&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F305403</link>
            <description>The relationships of renal and glomerular hypertrophies to development of hyperfiltration and proteinuria early in streptozotocin-induced diabetes were explored. Control, diabetic, phlorizin-treated controls, and diabetic male Fischer rats were used. Phlorizin (an Na+-glucose cotransport inhibitor) was given at a dose sufficient to normalize blood glucose. Inulin clearance (Cinulin) and protein excretion rate (PER) were measured. For morphometry, kidney sections were stained with periodic acid Schiff. At one week, diabetes PER increased 2.8-folds (P&amp;#x003C;.001), Cinulin increased 80&amp;#37; (P&amp;#x003C;.01). Kidney wet and dry weights increased 10&amp;#37;&amp;#8211;12&amp;#37; (P&amp;#x003C;.05), and glomerular tuft area increased 9.3&amp;#37; (P&amp;#x003C;.001). Phlorizin prevented proteinuria, hyperfiltration, an...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1734737</comments>
            <pubDate>Wed, 27 Aug 2008 14:28:41 +0100</pubDate>
            <guid isPermaLink="false">1734737</guid>        </item>
        <item>
            <title>Maternal Enterovirus Infection during Pregnancy as a Risk Factor in Offspring Diagnosed with Type 1 Diabetes between 15 and 30 Years of Age</title>
            <link>http://www.medworm.com/index.php?rid=1658344&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F271958</link>
            <description>Maternal enterovirus infections during pregnancy may increase the risk of offspring developing type 1 diabetes during childhood. The aim of this study was to investigate whether gestational enterovirus infections increase the offspring&amp;#39;s risk of type 1 diabetes later in life. Serum samples from 30 mothers without diabetes whose offspring developed type 1 diabetes between 15 and 25 years of age were analyzed for enterovirus-specific immunoglobulin M (IgM) antibodies and enterovirus genome (RNA), and compared to a control group. Among the index mothers, 9/30 (30&amp;#37;) were enterovirus IgM-positive, and none was positive for enterovirus RNA. In the control group, 14/90 (16&amp;#37;) were enterovirus IgM-positive, and 4/90 (4&amp;#37;) were positive for enterovirus RNA (n.s.). Boys of enterovirus ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1658344</comments>
            <pubDate>Mon, 28 Jul 2008 12:43:50 +0100</pubDate>
            <guid isPermaLink="false">1658344</guid>        </item>
        <item>
            <title>Role of C-Peptide in the Regulation of Microvascular Blood Flow</title>
            <link>http://www.medworm.com/index.php?rid=1658343&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F176245</link>
            <description>During the recent years, the role of C-peptide, released from the pancreatic beta cell, in regulating microvascular blood flow, has received increasing attention. In type 1 diabetic patients, intravenous application of C-peptide in physiological concentrations was shown to increase microvascular blood flow, and to improve microvascular endothelial function and the endothelial release of NO. C-peptide was shown to impact microvascular blood flow by several interactive pathways, like stimulating Na+K+ATPase or the endothelial release of NO. There is increasing evidence, that in patients with declining beta cell function, the lack of C-peptide secretion might play a putative role in the development of microvascular blood flow abnormalities, which go beyond the effects of declining insulin sec...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1658343</comments>
            <pubDate>Mon, 28 Jul 2008 12:43:50 +0100</pubDate>
            <guid isPermaLink="false">1658343</guid>        </item>
        <item>
            <title>Pancreatic Beta-Cell Purification by Altering FAD and NAD(P)H Metabolism</title>
            <link>http://www.medworm.com/index.php?rid=1658342&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F165360</link>
            <description>In this study, we investigated whether rat beta cells can be isolated from nonbeta endocrine cells by manipulating the flavin adenine dinucleotide (FAD) and nicotinamide-adenine dinucleotide phosphate (NAD(P)H) autofluorescence. Beta cells were isolated from dispersed islets by flow cytometry, based on their high FAD and NAD(P)H fluorescence. To improve beta cell yield and purity, the cellular FAD and NAD(P)H contents were altered by preincubation in culture media containing varying amounts of D-glucose and amino acids. Manipulation of the cellular FAD and NAD(P)H fluorescence improves beta cell yield and purity after sorting. This method is also a fast and reliable method to measure beta cell functional viability. A conceivable application is assessing beta cell viability before transplan...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1658342</comments>
            <pubDate>Mon, 28 Jul 2008 12:43:50 +0100</pubDate>
            <guid isPermaLink="false">1658342</guid>        </item>
        <item>
            <title>Disturbed &amp;#x03B1;-Cell Function in Mice with &amp;#x03B2;-Cell Specific Overexpression of Human Islet Amyloid Polypeptide</title>
            <link>http://www.medworm.com/index.php?rid=1583190&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F304513</link>
            <description>This study examined &amp;#x03B1;-cell function in mice with &amp;#x03B2;-cell specific overexpression of human IAPP (hIAPP) after an oral protein gavage (75&amp;#x2009;mg whey protein/mouse). Baseline glucagon levels were higher in transgenic mice (41&amp;#x00B1;4.0&amp;#x2009;pg/mL, n=6) than in wildtype animals (19&amp;#x00B1;5.1&amp;#x2009;pg/mL, n=5, P=.015). In contrast, the glucagon response to protein was impaired in transgenic animals (21&amp;#x00B1;2.7&amp;#x2009;pg/mL in transgenic mice versus 38&amp;#x00B1;5.7&amp;#x2009;pg/mL in wildtype mice at 15 minutes; P=.027). Baseline insulin levels did not differ between the groups, while the insulin response, as the glucagon response, was impaired after protein challenge (P=.018). Glucose levels were not different between the groups and did not change significantly after protein...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1583190</comments>
            <pubDate>Mon, 07 Jul 2008 11:38:07 +0100</pubDate>
            <guid isPermaLink="false">1583190</guid>        </item>
        <item>
            <title>Acute-Phase Serum Amyloid A as a Marker of Insulin Resistance in Mice</title>
            <link>http://www.medworm.com/index.php?rid=1536822&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F230837</link>
            <description>Acute-phase serum amyloid A (A-SAA) was shown recently to correlate with obesity and insulin resistance in humans. However, the mechanisms linking obesity-associated inflammation and elevated plasma A-SAA to insulin resistance are poorly understood. Using high-fat diet- (HFD-) fed mice, we found that plasma A-SAA was increased early upon HFD feeding and was tightly associated with systemic insulin resistance. Plasma A-SAA elevation was due to induction of Saa1 and Saa2 expression in liver but not in adipose tissue. In adipose tissue Saa3 was the predominant isoform and the earliest inflammatory marker induced, suggesting it is important for initiation of adipose tissue inflammation. To assess the potential impact of A-SAA on adipose tissue insulin resistance, we treated 3T3-L1 adipocytes w...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1536822</comments>
            <pubDate>Sun, 22 Jun 2008 21:59:24 +0100</pubDate>
            <guid isPermaLink="false">1536822</guid>        </item>
        <item>
            <title>The Role of the 14&amp;#8211;20 Domain of the Islet Amyloid Polypeptide in Amyloid Formation</title>
            <link>http://www.medworm.com/index.php?rid=1510094&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F256954</link>
            <description>The molecular mechanism of amyloid formation by the islet amyloid polypeptide (IAPP) has been intensively studied since its identification in the late 1980s. The IAPP(20&amp;#8211;29) region is considered to be the central amyloidogenic module of the polypeptide. This assumption is mainly based on the amyloidogenic properties of the region and on the large sequence diversity within this region between the human and mouse IAPP, as the mouse IAPP does not form amyloids. A few years ago, another region within IAPP was identified that seems to be at least as important as IAPP(20&amp;#8211;29) in facilitation of molecular recognition that leads to amyloid formation. Here, we reinforce our and others' previous findings by analyzing supporting evidence from the recent literature. Moreover, we provide new...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1510094</comments>
            <pubDate>Thu, 12 Jun 2008 00:38:33 +0100</pubDate>
            <guid isPermaLink="false">1510094</guid>        </item>
        <item>
            <title>Real-Time Monitoring of Apoptosis by Caspase-3-Like Protease Induced FRET Reduction Triggered by Amyloid Aggregation</title>
            <link>http://www.medworm.com/index.php?rid=1510093&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F865850</link>
            <description>Amyloid formation is cytotoxic and can activate the caspase cascade. Here, we monitor caspase-3-like activity as reduction of fluorescence resonance energy transfer (FRET) using the contstruct pFRET2-DEVD containing enhanced cyan fluorescent protin (EYFP) linked by the caspase-3 specific cleavage site residues DEVD. Beta-TC-6 cells were transfected, and the fluoorescence was measured at 440&amp;#x2009;nm excitation and 535&amp;#x2009;nm (EYFP) and 480&amp;#x2009;nm (ECFP) emission wavelength. Cells were incubated with recombinant pro lset Amyloid Polypeptide (rec prolAPP) or the processing metabolites of prolAPP;  the N-terminal flanking peptide withIAPP (recN+IAPP); IAPP with the C-terminal flanking peptied (recIAPP+C) and lslet Amyloid Polypeptide (recIAPP) . Peptides were added in solubilized from ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1510093</comments>
            <pubDate>Thu, 12 Jun 2008 00:38:33 +0100</pubDate>
            <guid isPermaLink="false">1510093</guid>        </item>
        <item>
            <title>Diabetes Alters Contraction-Induced Mitogen Activated Protein Kinase Activation in the Rat Soleus and Plantaris</title>
            <link>http://www.medworm.com/index.php?rid=1492683&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F738101</link>
            <description>The prescription of anaerobic exercise has recently been advocated for the management of diabetes; however exercise-induced signaling in diabetic muscle remains largely unexplored. Evidence from exercise studies in nondiabetics suggests that the extracellular-signal-regulated kinases (Erk1/2), p38, and c-JUN NH2-terminal kinase (Jnk) mitogen-activated protein kinases (MAPKs) are important regulators of muscle adaptation. Here, we compare the basal and the in situ contraction-induced phosphorylation of Erk1/2- p38- and Jnk-MAPK and their downstream targets (p90rsk and MAPKAP-K2) in the plantaris and soleus muscles of normal and obese (fa/fa) Zucker rats. Compared to lean animals, the time course and magnitude of Erk1/2, p90rsk and p38 phosphorylation to a single bout of contractile stimuli ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1492683</comments>
            <pubDate>Wed, 04 Jun 2008 17:33:04 +0100</pubDate>
            <guid isPermaLink="false">1492683</guid>        </item>
        <item>
            <title>Ins1 Gene Up-Regulated in a &amp;#x3B2;-Cell Line Derived from Ins2 Knockout Mice</title>
            <link>http://www.medworm.com/index.php?rid=1489638&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1080%2F15438600303730</link>
            <description>The authors have derived a new &amp;#x3B2;-cell line
(&amp;#x03B2;Ins2&amp;#x2212;/&amp;#x2212;lacZ) from Ins2&amp;#x2212;/&amp;#x2212; mice that carry the lacZ
reporter gene under control of the Ins2 promoter.
&amp;#x03B2;Ins2&amp;#x2212;/&amp;#x2212;lacZ cells stained positively using anti-insulin
antibody, expressed &amp;#x3B2;-cell–specific genes encoding the
transcription factor PDX-1, glucokinase, and Glut-2, retained
glucose-responsiveness for insulin secretion, and expressed
the lacZ gene. Analysis of Ins1 expression by reverse
transcriptase–polymerase chain reaction (RT-PCR)
showed that Ins1 transcripts were significantly raised to
compensate for the lack of Ins2 transcripts in &amp;#x03B2;Ins2&amp;#x2212;/&amp;#x2212;lacZ
cells, as compared to those found in &amp;#x3B2;TC1 cells expressing
both Ins1/Ins2. Thus, transcriptional up-...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489638</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489638</guid>        </item>
        <item>
            <title>&amp;#x3B2;-Cell Expansion for Therapeutic Compensation of Insulin Resistance in Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1489637&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1080%2F15438600303731</link>
            <description>Insulin resistance is the primary cause of type 2 diabetes.
However, if compensated by increased insulin production,
insulin resistance by itself does not lead to overt
disease. Type 2 diabetes develops when this compensation
is insufficient, due to defects in &amp;#x3B2;-cell function and in regulation
of the &amp;#x3B2;-cell mass. &amp;#x3B2;-Cell transplantation, as well
as approaches that replenish or preserve the endogenous
&amp;#x3B2;-cell mass, may facilitate the treatment of type 2 diabetes
in patients requiring exogenous insulin. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489637</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489637</guid>        </item>
        <item>
            <title>Effect of L-Carnitine on Skeletal Muscle Lipids and Oxidative Stress in Rats Fed High-Fructose Diet</title>
            <link>http://www.medworm.com/index.php?rid=1489636&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F72741</link>
            <description>There is evidence that high-fructose diet induces insulin resistance, alterations in lipid metabolism, and oxidative stress in rat tissues. The purpose of this study was to evaluate the effect of L-carnitine (CAR) on lipid accumulation and peroxidative damage in skeletal muscle of rats fed high-fructose diet. Fructose-fed animals (60 g/100 g diet) displayed decreased glucose/insulin (G/I) ratio and insulin sensitivity index (ISI0,120) indicating the development of insulin resistance. Rats showed alterations in the levels of triglycerides, free fatty acids, cholesterol, and phospholipids in skeletal muscle. The condition was associated with oxidative stress as evidenced by the accumulation of lipid peroxidation products, protein carbonyls, and aldehydes along with depletion of both enzymic ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489636</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489636</guid>        </item>
        <item>
            <title>Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1489635&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F51837</link>
            <description>Breakdown of the inner blood-retinal barrier (iBRB) occurs early in diabetes and is central to the development of sight-threatening diabetic macular edema (DME) as retinopathy progresses. In the current study, we examined how advanced glycation end products (AGEs) forming early in diabetes could modulate vasopermeability factor expression in the diabetic retina and alter inter-endothelial cell tight junction (TJ) integrity leading to iBRB dysfunction. We also investigated the potential for an AGE inhibitor to prevent this acute pathology and examined a role of the AGE-binding protein galectin-3 (Gal-3) in AGE-mediated cell retinal pathophysiology. Diabetes was induced in C57/BL6 wild-type (WT) mice and in Gal-3&amp;#x2212;/&amp;#x2212; transgenic mice. Blood glucose was monitored and AGE levels we...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489635</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489635</guid>        </item>
        <item>
            <title>Oxidative Stress and Diabetic Retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=1489634&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F43603</link>
            <description>Oxygen metabolism is essential for sustaining aerobic life, and normal cellular homeostasis works on a fine balance between the formation and elimination of reactive oxygen species (ROS). Oxidative stress, a cytopathic consequence of excessive production of ROS and the suppression of ROS removal by antioxidant defense system, is implicated in the development of many diseases, including Alzheimer&amp;#39;s disease, and diabetes and its complications. Retinopathy, a debilitating microvascular complication of diabetes, is the leading cause of acquired blindness in developed countries. Many diabetes-induced metabolic abnormalities are implicated in its development, and appear to be influenced by elevated oxidative stress; however the exact mechanism of its development remains elusive. Increased su...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489634</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489634</guid>        </item>
        <item>
            <title>Further Studies on Antioxidant Potential and Protection of Pancreatic &amp;#x03B2;-Cells by Embelia ribes in Experimental Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1489633&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F15803</link>
            <description>This study was designed to examine the antioxidant defense by ethanolic extract of Embelia ribes on streptozotocin-(40 mg/kg, intravenously, single-injection) induced diabetes in Wistar rats. Forty days of oral feeding the extract (100 mg/kg and 200 mg/kg) to diabetic rats resulted in significant (P&amp;#x003C;.01) decrease in blood glucose, blood glycosylated haemoglobin, serum lactate dehydrogenase, creatine kinase, and increase in blood glutathione levels as compared to pathogenic diabetic rats. Further, the extract also significantly (P&amp;#x003C;.01) decreased the pancreatic thiobarbituric acid-reactive substances (TBARS) levels and significantly (P&amp;#x003C;.01) increased the superoxide dismutase, catalase, and glutathione levels as compared to above levels in pancreatic tissue of pathogenic ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489633</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489633</guid>        </item>
        <item>
            <title>Metabolic Memory Phenomenon and Accumulation of Peroxynitrite in Retinal Capillaries</title>
            <link>http://www.medworm.com/index.php?rid=1489632&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F21976</link>
            <description>Conclusions. Peroxynitrite accumulation in the retinal microvasculature, the site of histopathology, fails to normalize after reversal of hyperglycemia, and superoxide remains inadequately scavenged. This failure of reversal of peroxynitrite accumulation could be, in part, responsible for the resistance of diabetic retinopathy to reverse after termination of PC. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489632</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489632</guid>        </item>
        <item>
            <title>A Role for Excitatory Amino Acids in Diabetic Eye Disease</title>
            <link>http://www.medworm.com/index.php?rid=1489631&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F36150</link>
            <description>Diabetic retinopathy is a leading cause of vision loss. The primary clinical hallmarks are vascular changes that appear to contribute to the loss of sight. In a number of neurodegenerative disorders there is an appreciation that increased levels of excitatory amino acids are excitotoxic. The primary amino acid responsible appears to be the neurotransmitter glutamate. This review examines the nature of glutamatergic signaling at the retina and the growing evidence from clinical and animal model studies that glutamate may be playing similar excitotoxic roles at the diabetic retina. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489631</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489631</guid>        </item>
        <item>
            <title>Detection of Elevated Signaling Amino Acids in Human Diabetic Vitreous by Rapid Capillary Electrophoresis</title>
            <link>http://www.medworm.com/index.php?rid=1489630&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F39765</link>
            <description>Elevated glutamate is implicated in the pathology of PDR. The ability to rapidly assess the glutamate and amino acid content of vitreous provides a more complete picture of the chemical changes occurring at the diabetic retina and may lead to a better understanding of the pathology of PDR. Vitreous humor was collected following vitrectomies of patients with PDR and control conditions of macular hole or epiretinal membrane. A capillary electrophoresis method was developed to quantify glutamate and arginine. The analysis is relatively fast (&amp;#x003C;6 minutes) and utilizes a poly(ethylene)oxide and sodium dodecylsulfate run buffer. Both amino acid levels show significant increases in PDR patients versus controls and are comparable to other reports. The levels of vitreal glutamate vary inverse...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489630</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489630</guid>        </item>
        <item>
            <title>Pharmacotherapies for Diabetic Retinopathy: Present and Future</title>
            <link>http://www.medworm.com/index.php?rid=1489629&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F52487</link>
            <description>Diabetic retinopathy remains a major cause of worldwide preventable blindness. Measures to avoid blindness include medical management (control of blood sugar, blood pressure, and serum lipids) and ocular management (laser photocoagulation and pars plana vitrectomy). Adjunctive pharmacologic therapies (intravitreal triamcinolone acetonide and anti-vascular endothelial growth factor agents) have shown early promise in the treatment of both diabetic macular edema and proliferative diabetic retinopathy. Other medications under investigation include the fluocinolone acetonide implantable device, extended-release dexamethasone implant, oral ruboxistaurin, and intravitreal hyaluronidase. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489629</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489629</guid>        </item>
        <item>
            <title>The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient</title>
            <link>http://www.medworm.com/index.php?rid=1489628&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F61038</link>
            <description>The polyol pathway is a two-step metabolic pathway in which glucose is reduced to sorbitol, which is then converted to fructose. It is one of the most attractive candidate mechanisms to explain, at least in part, the cellular toxicity of diabetic hyperglycemia because (i) it becomes active when intracellular glucose concentrations are elevated, (ii) the two enzymes are present in human tissues and organs that are sites of diabetic complications, and (iii) the products of the pathway and the altered balance of cofactors generate the types of cellular stress that occur at the sites of diabetic complications. Inhibition (or ablation) of aldose reductase, the first and rate-limiting enzyme in the pathway, reproducibly prevents diabetic retinopathy in diabetic rodent models, but the results of ...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489628</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489628</guid>        </item>
        <item>
            <title>Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=1489627&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F95103</link>
            <description>Diabetes causes metabolic and physiologic abnormalities in the retina, and these changes suggest a role for inflammation in the development of diabetic retinopathy. These changes include upregulation of iNOS, COX-2, ICAM-1, caspase 1, VEGF, and NF-&amp;#x03BA;B, increased production of nitric oxide, prostaglandin E2, IL-1&amp;#x03B2;, and cytokines, as well as increased permeability and leukostasis. Using selective pharmacologic inhibitors or genetically modified animals, an increasing number of therapeutic approaches have been identified that significantly inhibit development of at least the early stages of diabetic retinopathy, especially occlusion and degeneration of retinal capillaries. A common feature of a number of these therapies is that they inhibit production of inflammatory mediators. T...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489627</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489627</guid>        </item>
        <item>
            <title>Effect of Siraitia Grosvenorii Polysaccharide on Glucose and Lipid of Diabetic Rabbits
Induced by Feeding High Fat/High Sucrose Chow</title>
            <link>http://www.medworm.com/index.php?rid=1489626&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F67435</link>
            <description>The Siraitia grosvenorii polysaccharide (SGP) from the Siraitia grosvenorii (Swingle) was isolated and purified. The therapeutic effects of SGP on diabetic rabbits induced by feeding high fat/high sucrose chow were studied. After administration of SGP for 4 weeks, the fasting blood glucose (FBG), plasma insulin levels (INS), plasma total cholesterol (TC), triglyceride (TG), and HDL-C were assayed. The results showed that administration of SGP can significantly decrease plasma total cholesterol, triglyceride, and glucose levels; and increase HDL-C levels after 4 weeks of treatment. The antihyperglycaemic effect of SGP at dose of 100&amp;#x2009;mg&amp;#8901;kg&amp;#8722;1 bw was the most significant in three dosage groups. Furthermore, SGP could restore the blood lipid levels of diabetic rabbits (P&amp;#x00...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489626</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489626</guid>        </item>
        <item>
            <title>Cellular Signaling and Potential New Treatment Targets in Diabetic Retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=1489625&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F31867</link>
            <description>Dysfunction and death of microvascular cells and imbalance between the production and the degradation of extracellular matrix (ECM) proteins are a characteristic feature of diabetic retinopathy (DR). Glucose-induced biochemical alterations in the vascular endothelial cells may activate a cascade of signaling pathways leading to increased production of ECM proteins and cellular dysfunction/death. Chronic diabetes leads to the activation of a number of signaling proteins including protein kinase C, protein kinase B, and mitogen-activated protein kinases. These signaling cascades are activated in response to hyperglycemia-induced oxidative stress, polyol pathway, and advanced glycation end product formation among others. The aberrant signaling pathways ultimately lead to activation of transcr...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489625</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489625</guid>        </item>
        <item>
            <title>Diabetic Retinopathy in Native and Nonnative Canadians</title>
            <link>http://www.medworm.com/index.php?rid=1489624&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F76271</link>
            <description>High prevalence rates of type 2 diabetes are being observed in native Canadian communities. It is believed that native populations have a higher prevalence rate of vascular complications than nonnatives. The Southern Alberta Study of Diabetic Retinopathy (DR) examined the prevalence and incidence of DR and associated metabolic abnormalities in native and nonnative subjects. Prevalence rates of DR in type 2 diabetic native and nonnative subjects were identical, with a prevalence rate of 40&amp;#37;. Native subjects with retinopathy, however, tended to have more advanced changes of retinopathy compared to the nonnative subjects. Key factors such as A1c, blood pressure, duration of diabetes, and lipid values were not significantly different between the two cohorts. These data indicate that ethnic...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489624</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489624</guid>        </item>
        <item>
            <title>Diabetic Retinopathy: From Pathogenesis to Treatment</title>
            <link>http://www.medworm.com/index.php?rid=1489623&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2007%2F69527</link>
            <description>(Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489623</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489623</guid>        </item>
        <item>
            <title>Effect of C-Peptide on Diabetic Neuropathy in Patients with Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1489622&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F457912</link>
            <description>Recent results indicate that proinsulin C-peptide, contrary 
  to previous views, exerts important physiological effects and 
  shows the characteristics of a bioactive peptide. Studies in 
  type 1 diabetes, involving animal models as well as patients, 
  demonstrate that C-peptide in replacement doses has the 
  ability to improve peripheral nerve function and prevent or 
  reverse the development of nerve structural abnormalities. 
  Peripheral nerve function, as evaluated by determination of 
  sensory nerve conduction velocity and quantitative sensory 
  testing, is improved by C-peptide replacement in diabetes type 
  1 patients with early stage neuropathy. Similarly, autonomic 
  nerve dysfunction is ameliorated following administration of C 
  peptide for up to 3 months. As evaluat...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489622</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489622</guid>        </item>
        <item>
            <title>Effects of Oral Glucose Load on Endothelial Function and on Insulin and Glucose Fluctuations in Healthy Individuals</title>
            <link>http://www.medworm.com/index.php?rid=1489621&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F672021</link>
            <description>Conclusion. Oral glucose load does not induce 
endothelial dysfunction in healthy individuals with mean insulin 
and glucose values of 5.6&amp;#x2009;mmol/L and 27.2&amp;#x2009;mmol/L, 
respectively, 2 hours after glucose load. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489621</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489621</guid>        </item>
        <item>
            <title>Intracellular Signalling by C-Peptide</title>
            <link>http://www.medworm.com/index.php?rid=1489620&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F635158</link>
            <description>C-peptide, a cleavage product of the proinsulin molecule, has long been regarded as biologically inert, serving merely as a surrogate marker for insulin release. Recent findings demonstrate both a physiological and protective role of C-peptide when administered to individuals with type I diabetes. Data indicate that C-peptide appears to bind in nanomolar concentrations to a cell surface receptor which is most likely to be G-protein coupled. Binding of C-peptide initiates multiple cellular effects, evoking a rise in intracellular calcium, increased PI-3-kinase activity, stimulation of the Na+/K+ ATPase, increased eNOS transcription, and activation of the MAPK signalling pathway. These cell signalling effects have been studied in multiple cell types from multiple tissues. Overall these obser...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489620</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489620</guid>        </item>
        <item>
            <title>Influence of C-Peptide on Glucose Utilisation</title>
            <link>http://www.medworm.com/index.php?rid=1489619&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F769483</link>
            <description>During the recent years, multiple studies demonstrated that C-peptide is not an inert peptide, but exerts important physiological effects. C-peptide binds to cell membranes, stimulates the Na,K-ATPase and the endothelial nitric oxide (NO) synthase. Moreover, there is evidence that C-peptide decreases glomerular hyperfiltration and increases glucose utilisation. Nevertheless, there is still limited knowledge concerning mechanisms leading to an increased glucose utilisation either in rats or in humans. The aim of this paper is to give an overview over the published studies regarding C-peptide and glucose metabolism from in vitro studies to longer lasting studies in humans. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489619</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489619</guid>        </item>
        <item>
            <title>C-Peptide and Atherogenesis: C-Peptide as a Mediator of Lesion Development in Patients with Type 2 Diabetes Mellitus?</title>
            <link>http://www.medworm.com/index.php?rid=1489618&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F385108</link>
            <description>Patients with insulin resistance and early type 2 diabetes exhibit an increased propensity to develop a diffuse and extensive pattern of arteriosclerosis. Typically, these patients show increased levels of C-peptide and over the last years various groups examined the effect of C-peptide in vascular cells as well as its potential role in lesion development. While some studies demonstrated beneficial effects of C-peptide, for example, by showing an inhibition of smooth muscle cell proliferation, others suggested proatherogenic mechanisms in patients with type 2 diabetes. Among them, C-peptide may facilitate the recruitment of inflammatory cells into early lesions and promote lesion progression by inducing smooth muscle cell proliferation. The following review will summarize the effects of C-...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489618</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489618</guid>        </item>
        <item>
            <title>AGEs and Glucose Levels Modulate Type I and III Procollagen mRNA Synthesis in Dermal Fibroblasts Cells Culture</title>
            <link>http://www.medworm.com/index.php?rid=1489617&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F473603</link>
            <description>In the dermis, fibroblasts play an important role in the turnover of the dermal extracellular matrix. Collagen I and III, the most important dermal proteins of the extracellular matrix, are progressively altered during ageing and diabetes. For mimicking diabetic conditions, the cultured human dermal fibroblasts were incubated with increasing amounts of AGE-modified BSA and D-glucose for 24 hours. The expression of procollagen &amp;#x03B1;2(I) and procollagen &amp;#x03B1;1(III) mRNA was analyzed by quantitative real-time PCR. Our data revealed that the treatment of fibroblasts with AGE-modified BSA upregulated the expression of procollagen &amp;#x03B1;2(I) and procollagen &amp;#x03B1;1(III) mRNA in a dose-dependent manner. High glucose levels mildly induced a profibrogenic pattern, increasing the procollag...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489617</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489617</guid>        </item>
        <item>
            <title>Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide</title>
            <link>http://www.medworm.com/index.php?rid=1489616&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F819123</link>
            <description>Patients with fulminant type 1 diabetes almost completely lack
C-peptide even soon after the onset of the disease, and the deficiency
continues for the rest of their life. Thus, fulminant type 1 diabetes
could serve as a good model of nature to explore the physiological role
of C-peptide. For example, patients with fulminant type 1 diabetes have
diabetic chronic complications more frequently than those with classical
autoimmune type 1 diabetes 5 years after the onset of diabetes, and the
higher prevalence could be partly attributable to the complete lack of
C-peptide in fulminant type 1 diabetes. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489616</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489616</guid>        </item>
        <item>
            <title>The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor-rat</title>
            <link>http://www.medworm.com/index.php?rid=1489615&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F230458</link>
            <description>Diabetic polyneuropathy (DPN) occurs more frequently in type 1 diabetes resulting in a more severe DPN. The differences in DPN between the two types of diabetes are due to differences in the availability of insulin and C-peptide. Insulin and C-peptide provide gene regulatory effects on neurotrophic factors with effects on axonal cytoskeletal proteins and nerve fiber integrity. A significant abnormality in type 1 DPN is nodal degeneration. In the type 1 BB/Wor-rat, C-peptide replacement corrects metabolic abnormalities ameliorating the acute nerve conduction defect. It corrects abnormalities of neurotrophic factors and the expression of neuroskeletal proteins with improvements of axonal size and function. C-peptide corrects the expression of nodal adhesive molecules with prevention and repa...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489615</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489615</guid>        </item>
        <item>
            <title>Radioiodinated Naphthylalanine Derivatives Targeting Pancreatic Beta Cells in Normal and Nonobese Diabetic Mice</title>
            <link>http://www.medworm.com/index.php?rid=1489614&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F371716</link>
            <description>An imaging method capable of using a signal from pancreatic beta cells to determine their mass would be of immense value in monitoring the progression of diabetes as well as response to treatment. Somatostatin receptors (SSTRs) are expressed on beta cells and are a potential target for imaging. The main objective of this study was to investigate whether pancreatic beta cells are a target for radiolabeled naphthylalanine derivatives. The molecules were subjected to in vitro and ex vivo evaluations. Pancreatic uptake of radioactivity was lower in nonobese diabetic (NOD) mice than normal mice at all time points investigated (P &amp;#60; .05) and correlated with the number of islets in tissue sections of both control and NOD mice. Immunohistochemical and confocal fluorescent microscopic studies sh...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489614</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489614</guid>        </item>
        <item>
            <title>C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients</title>
            <link>http://www.medworm.com/index.php?rid=1489613&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F730594</link>
            <description>Conclusion/interpretation. C-peptide and its C-terminal fragments are equally effective in improving erythrocyte deformability in type 1 diabetes. The C-terminal residues of C-peptide are causally involved in this effect. The signal transduction pathway is Ca2+-dependent and involves activation of red blood cell Na+,K+-ATPase. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489613</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489613</guid>        </item>
        <item>
            <title>Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in &amp;#x03B2;-Cell Death  in Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=1489612&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F421287</link>
            <description>The presence of fibrillar protein deposits (amyloid) of human islet amyloid polypeptide (hIAPP) in the pancreatic islets of Langerhans is thought to be related to death of the insulin-producing islet &amp;#x03B2;-cells in type 2 diabetes mellitus (DM2). The mechanism of hIAPP-induced &amp;#x03B2;-cell death is not understood. However, there is growing evidence that hIAPP-induced disruption of &amp;#x03B2;-cell membranes is the cause of hIAPP cytotoxicity. Amyloid cytotoxicity by membrane damage has not only been suggested for hIAPP, but also for peptides and proteins related to other misfolding diseases, like Alzheimer_s disease, Parkinson&amp;#39;s disease, and prion diseases. Here we review the interaction of hIAPP with membranes, and discuss recent progress in the field, with a focus on hIAPP structure...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489612</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489612</guid>        </item>
        <item>
            <title>Human Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=1489611&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F697035</link>
            <description>In this study, we found that after a long-term, high-fat diet challenge islet amyloid was observed in only 4 of 19 hIAPP transgenic mice. hIAPP transgenic females exhibited severe glucose intolerance, which was associated with a downregulation of GLUT-2 mRNA expression. In isolated islets from hIAPP males cultured for 3 weeks on high-glucose medium, the percentage of amyloid containing islets increased from 5.5&amp;#37; to 70&amp;#37;. This ex vivo system will allow a more rapid, convenient, and specific study of factors influencing islet amyloidosis as well as of therapeutic strategies to interfere with this pathological process. (Source: Experimental Diabetes Research)</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489611</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489611</guid>        </item>
        <item>
            <title>History and Diagnostic Significance of C-Peptide</title>
            <link>http://www.medworm.com/index.php?rid=1489610&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F576862</link>
            <description>Starting with the epoch-making discovery of proinsulin, C-peptide has played an important interdisciplinary role, both as part of the single-chain precursor molecule and as an individual entity. In the pioneering years, fundamental systematic experiments unravelled new biochemical mechanisms and chemical structures. After the first detection of C-peptide in human serum, it quickly became a most useful independent indicator of insulin biosynthesis and secretion, finding application in a rapidly growing number of clinical investigations. A prerequisite was the development of specific immuno assays for proinsulin and C-peptide.
Further milestones were: the chemical synthesis of several C-peptides and the accomplishments in the synthesis of proinsulin; the detection of preproinsulin with its b...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489610</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489610</guid>        </item>
        <item>
            <title>C-Peptide Effects on Renal Physiology and Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1489609&amp;cid=s_37026_15_f&amp;fid=37026&amp;url=http%3A%2F%2Fwww.hindawi.com%2FGetArticle.aspx%3Fdoi%3D10.1155%2F2008%2F281536</link>
            <description>The C-peptide of proinsulin is important for the biosynthesis of insulin and has for a long time been considered to be biologically inert. Animal studies have shown that some of the renal effects of the C-peptide may in part be explained by its ability to stimulate the Na,K-ATPase activity. Precisely, the C-peptide reduces diabetes-induced glomerular hyperfiltration both in animals and humans, therefore, resulting in regression of fibrosis. The tubular function is also concerned as diabetic animals supplemented with C-peptide exhibit better renal function resulting in reduced urinary sodium waste and protein excretion together with the reduction of the diabetes-induced glomerular hyperfiltration. The tubular effectors of C-peptide were considered to be tubule transporters, but recent studi...</description>
            <author>Experimental Diabetes Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1489609</comments>
            <pubDate>Tue, 03 Jun 2008 22:14:09 +0100</pubDate>
            <guid isPermaLink="false">1489609</guid>        </item>
    </channel>
</rss>
